Total Payments
$6,001
2024 Payments
$740.72
Companies
48
Transactions
387
Medicare Patients
1,642
Medicare Billing
$125,970
Payment Breakdown by Category
Food & Beverage$6,001 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,001 | 387 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $928.43 | 51 | $0 (2024) |
| PFIZER INC. | $843.74 | 65 | $0 (2024) |
| Lilly USA, LLC | $572.24 | 33 | $0 (2024) |
| Shire North American Group Inc | $476.25 | 35 | $0 (2019) |
| Novo Nordisk Inc | $375.69 | 29 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $248.26 | 21 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $176.19 | 12 | $0 (2023) |
| GlaxoSmithKline, LLC. | $173.12 | 7 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $164.64 | 13 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $151.93 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $740.72 | 39 | ABBVIE INC. ($264.48) |
| 2023 | $878.29 | 51 | ABBVIE INC. ($190.73) |
| 2022 | $1,001 | 55 | ABBVIE INC. ($301.96) |
| 2021 | $987.29 | 64 | PFIZER INC. ($185.38) |
| 2020 | $754.16 | 56 | PFIZER INC. ($198.90) |
| 2019 | $562.26 | 47 | Shire North American Group Inc ($150.49) |
| 2018 | $350.38 | 26 | Shire North American Group Inc ($173.06) |
| 2017 | $727.32 | 49 | PFIZER INC. ($193.08) |
All Payment Transactions
387 individual payment records from CMS Open Payments — Page 16 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2017 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Diabetes | ||||||
| 03/31/2017 | PFIZER INC. | LYRICA (Drug), VIAGRA | Food and Beverage | In-kind items and services | $3.32 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/21/2017 | PFIZER INC. | LYRICA (Drug), VIAGRA | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/20/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Endocrinology | ||||||
| 03/08/2017 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2017 | Novo Nordisk Inc | Levemir (Drug), Tresiba, Victoza | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: Diabetes | ||||||
| 02/06/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: RESPIRATORY | ||||||
| 01/30/2017 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Endocrinology | ||||||
| 01/26/2017 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2017 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $44.06 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 01/03/2017 | PFIZER INC. | LYRICA (Drug), VIAGRA | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 411 | 553 | $81,340 | $36,951 |
| 2022 | 11 | 408 | 564 | $69,143 | $30,499 |
| 2021 | 11 | 386 | 512 | $62,391 | $29,406 |
| 2020 | 13 | 437 | 536 | $71,210 | $29,113 |
Total Patients
1,642
Total Services
2,165
Medicare Billing
$125,970
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 193 | $38,600 | $15,030 | 38.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 72 | 72 | $18,720 | $8,824 | 47.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $4,048 | $3,092 | 76.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 36 | 38 | $4,788 | $2,648 | 55.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 52 | $6,760 | $2,272 | 33.6% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 12 | 12 | $1,920 | $1,542 | 80.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 73 | 73 | $2,190 | $1,266 | 57.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 37 | $1,406 | $1,085 | 77.2% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 12 | 12 | $600.00 | $469.20 | 78.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 42 | $1,890 | $399.84 | 21.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $418.00 | $322.63 | 77.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 168 | $31,740 | $12,575 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 59 | 59 | $15,130 | $7,368 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 84 | $10,600 | $5,184 | 48.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 32 | 34 | $4,260 | $2,317 | 54.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 59 | 59 | $1,753 | $1,008 | 57.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 32 | 34 | $1,284 | $949.52 | 74.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 26 | 56 | $2,484 | $516.98 | 20.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $410.00 | $308.76 | 75.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 19 | 20 | $493.00 | $122.86 | 24.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 19 | 21 | $622.00 | $107.28 | 17.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 18 | $367.00 | $39.99 | 10.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 175 | $31,545 | $14,218 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 56 | 56 | $14,000 | $7,151 | 51.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 55 | $6,600 | $3,526 | 53.4% |
About Dr. Shawn Mcmanus, DO
Dr. Shawn Mcmanus, DO is a Family Medicine healthcare provider based in Lehi, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1376707323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shawn Mcmanus, DO has received a total of $6,001 in payments from pharmaceutical and medical device companies, with $740.72 received in 2024. These payments were reported across 387 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,001).
As a Medicare-enrolled provider, Mcmanus has provided services to 1,642 Medicare beneficiaries, totaling 2,165 services with total Medicare billing of $125,970. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lehi, UT
- Active Since 07/17/2008
- Last Updated 01/15/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376707323
Products in Payments
- VYVANSE (Drug) $509.34
- VRAYLAR (Drug) $431.05
- NURTEC ODT (Drug) $367.91
- UBRELVY (Drug) $345.11
- MOUNJARO (Drug) $189.66
- QULIPTA (Drug) $174.81
- MYDAYIS (Drug) $151.83
- TRULICITY (Drug) $140.97
- EUCRISA (Drug) $139.66
- COLOGUARD DNA CAPTURE REAGENTS (Device) $137.29
- Vascepa (Drug) $129.35
- FARXIGA (Drug) $120.46
- SHINGRIX (Biological) $117.73
- EMGALITY (Drug) $108.29
- SOLIQUA 100/33 (Biological) $103.95
- QELBREE (Drug) $99.26
- LYRICA (Drug) $88.78
- FLECTOR (Drug) $83.30
- JARDIANCE (Drug) $80.81
- Ozempic (Drug) $80.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lehi
Toran Macarthur, M.d, M.D
Family Medicine — Payments: $12,446
Family Medicine $12,446
Dr. Tauaina Ngatuvai, M.d, M.D
Family Medicine — Payments: $12,080
Family Medicine $12,080
Cheryl Johnson, M.d, M.D
Family Medicine — Payments: $11,288
Family Medicine $11,288
David Kimball, D.o., D.c, D.O., D.C
Family Medicine — Payments: $2,841
Family Medicine $2,841
Richard Sharp, M.d, M.D
Family Medicine — Payments: $879.34
Family Medicine $879.34
Dianne Farley Jones, Md, MD
Family Medicine — Payments: $769.67
Family Medicine $769.67